123 related articles for article (PubMed ID: 12415247)
1. Hepatitis C therapeutics: current status and emerging strategies.
Tan SL; Pause A; Shi Y; Sonenberg N
Nat Rev Drug Discov; 2002 Nov; 1(11):867-81. PubMed ID: 12415247
[TBL] [Abstract][Full Text] [Related]
2. Emerging host cell targets for hepatitis C therapy.
He Y; Duan W; Tan SL
Drug Discov Today; 2007 Mar; 12(5-6):209-17. PubMed ID: 17331885
[TBL] [Abstract][Full Text] [Related]
3. Challenges in modern drug discovery: a case study of boceprevir, an HCV protease inhibitor for the treatment of hepatitis C virus infection.
Njoroge FG; Chen KX; Shih NY; Piwinski JJ
Acc Chem Res; 2008 Jan; 41(1):50-9. PubMed ID: 18193821
[TBL] [Abstract][Full Text] [Related]
4. Development of a heterologous, multigenotype vaccine against hepatitis C virus infection.
Encke J; Radunz W; Eisenbach C; Geib J; Gehrke S; Pfaff E; Stremmel W
Eur J Clin Invest; 2007 May; 37(5):396-406. PubMed ID: 17461986
[TBL] [Abstract][Full Text] [Related]
5. Present and future therapy for hepatitis C virus.
Cornberg M; Deterding K; Manns MP
Expert Rev Anti Infect Ther; 2006 Oct; 4(5):781-93. PubMed ID: 17140355
[TBL] [Abstract][Full Text] [Related]
6. A primer on the molecular virology of hepatitis C.
Moradpour D; Blum HE
Liver Int; 2004 Dec; 24(6):519-25. PubMed ID: 15566499
[TBL] [Abstract][Full Text] [Related]
7. Progressive liver injury in chronic hepatitis C infection is related to altered cellular immune response and to different citokine profile.
Cecere A; Marotta F; Vangieri B; Tancredi L; Gattoni A
Panminerva Med; 2004 Sep; 46(3):171-87. PubMed ID: 15510086
[TBL] [Abstract][Full Text] [Related]
8. Vaccines and immunotherapies against hepatitis B and hepatitis C viruses.
Inchauspé G; Michel ML
J Viral Hepat; 2007 Nov; 14 Suppl 1():97-103. PubMed ID: 17958650
[TBL] [Abstract][Full Text] [Related]
9. HCV-hepatocellular carcinoma: new findings and hope for effective treatment.
Dash S; Haque S; Joshi V; Prabhu R; Hazari S; Fermin C; Garry R
Microsc Res Tech; 2005 Nov; 68(3-4):130-48. PubMed ID: 16276514
[TBL] [Abstract][Full Text] [Related]
10. [Molecular mechanisms of the hepatitis C virus, potential therapeutic targets].
Rivas-Estilla AM; Panduro A
Rev Invest Clin; 2003; 55(1):51-64. PubMed ID: 12708164
[TBL] [Abstract][Full Text] [Related]
11. Treatment of chronic hepatitis C virus infection - Dutch national guidelines.
de Bruijne J; Buster EH; Gelderblom HC; Brouwer JT; de Knegt RJ; van Erpecum KJ; Schalm SW; Bakker CM; Zaaijer HL; Janssen HL; Reesink HW;
Neth J Med; 2008; 66(7):311-22. PubMed ID: 18663263
[TBL] [Abstract][Full Text] [Related]
12. Novel approaches for therapy of chronic hepatitis C.
Stauber RE; Stadlbauer V
J Clin Virol; 2006 Jun; 36(2):87-94. PubMed ID: 16546442
[TBL] [Abstract][Full Text] [Related]
13. Selective inhibitors of hepatitis C virus replication.
Neyts J
Antiviral Res; 2006 Sep; 71(2-3):363-71. PubMed ID: 16843538
[TBL] [Abstract][Full Text] [Related]
14. [Immunomodulating effect of HCV during the development of chronic hepatitis C: toward new therapeutic approaches].
Stoll-Keller F; Schvoerer E; Thumann C; Navas MC; Aubertin AM
Bull Acad Natl Med; 2003; 187(6):1147-60; discussion 1160-1. PubMed ID: 14978874
[TBL] [Abstract][Full Text] [Related]
15. New therapeutic options for hepatitis C.
Waters L; Nelson M
Curr Opin Infect Dis; 2006 Dec; 19(6):615-22. PubMed ID: 17075339
[TBL] [Abstract][Full Text] [Related]
16. Current and future concepts in hepatitis C therapy.
Pawlotsky JM
Semin Liver Dis; 2005 Feb; 25(1):72-83. PubMed ID: 15731999
[TBL] [Abstract][Full Text] [Related]
17. Development of prophylactic and therapeutic vaccines against hepatitis C virus.
Leroux-Roels G
Expert Rev Vaccines; 2005 Jun; 4(3):351-71. PubMed ID: 16026249
[TBL] [Abstract][Full Text] [Related]
18. Virological effects of ISIS 14803, an antisense oligonucleotide inhibitor of hepatitis C virus (HCV) internal ribosome entry site (IRES), on HCV IRES in chronic hepatitis C patients and examination of the potential role of primary and secondary HCV resistance in the outcome of treatment.
Soler M; McHutchison JG; Kwoh TJ; Dorr FA; Pawlotsky JM
Antivir Ther; 2004 Dec; 9(6):953-68. PubMed ID: 15651754
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus--biology, host evasion strategies, and promising new therapies on the horizon.
Qureshi SA
Med Res Rev; 2007 May; 27(3):353-73. PubMed ID: 16958135
[TBL] [Abstract][Full Text] [Related]
20. Current and future management of chronic hepatitis C infection.
Cross TJ; Antoniades CG; Harrison PM
Postgrad Med J; 2008 Apr; 84(990):172-6. PubMed ID: 18424572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
